In accordance with the Japanese panel, Reuters ought to give folks 65 and over a precedence of a COVID vaccine
© Reuters. FILE PHOTO: Coronavirus disease (COVID-19) outbreak in Tokyo
TOKYO (Reuters) – A panel from Japan’s Ministry of Health said Friday that people 65 and over should be given priority vaccination against COVID-19 as the government sets guidelines that also prioritize frontline health workers and those with illness .
The panel also specified, among other things, chronic heart disease, chronic respiratory disease and chronic kidney disease as underlying diseases that should determine the priority of the vaccine.
The recommendations would include 36 million elderly people and 8.2 million people with conditions in the first group to receive vaccination shots.
Another government body this week recommended that priority be given to health professionals and workers in elderly care facilities, while older people and those with underlying health conditions should also be given priority.
Japan, of 126 million people, has made agreements to buy 290 million doses of vaccine from Pfizer Inc (NYSE :), AstraZeneca (NASDAQ 🙂 Plc and Modern (NASDAQ 🙂 Inc or enough for 145 million people.
Japan is currently facing a third wave of coronavirus infections that are putting a heavy strain on the country’s medical system.
Prime Minister Yoshihide Suga will hold a press conference on Friday on the government’s response to the pandemic.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, diagrams and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.